Octapharma Plasma
Financials
2020 Annual Revenue
€2.39 Billion
2020 Gross Profit
€840.48 Million
2020 Annual Net Income
€375.69 Million
2020 Fiscal Year Revenue Growth
8.09%
2020 Number of Stores
9,067
Credit Rating
No Publicly Rated Debt
Octapharma Plasma is a wholly-owned subsidiary of Octapharma AG, one of the world’s largest makers of plasma products. Based in Lachen, Switzerland, Octapharma AG has been committed to patient care and medical innovation since 1983. They have biopharmaceutical experience in 113 countries and employ more than 7,000 people globally.